2026年5月4日
HPV Biological Protein Dressing Successfully Listed in Guizhou Procurement Platform
Great News! Our HPV Biological Protein Dressing Successfully Listed on Guizhou Medical Consumables Procurement Platform
Recently, the Anti-Human Papillomavirus (HPV) Biological Protein Dressing under Wuhan Heyuan Biotechnology Co., Ltd. has successfully completed the listing procedure on the Drug and Medical Consumables Procurement Management System of Guizhou Province, and been officially included in the Guizhou Medical Consumables Procurement Platform. This marks that the product is qualified for compliant sales in medical institutions within Guizhou Province, and also represents a key step forward in the commercialization process of the company’s products!
About the Listed Product
The Anti-Human Papillomavirus (HPV) Biological Protein Dressing successfully listed this time is a Class II medical device independently developed by our company, which has obtained the medical device registration certificate issued by Hubei Provincial Medical Products Administration (Registration Certificate No.: E Medical Device Approval 20252185909).
The product is indicated for reducing local HPV viral load and can provide compliant intervention solutions for HPV-related health problems. The full range of specifications is covered in this listing.
Significance of Successful Listing
The listing of medical consumables is a critical step for products to enter the procurement system of medical institutions, as well as an important prerequisite for commercial implementation. The successful listing of the product in Guizhou Province is a milestone for the company:
- Breakthrough in Channel Access: The product has officially obtained the procurement qualification of medical institutions in Guizhou Province, paving the way for subsequent entry into hospitals at all levels and primary medical institutions, and greatly expanding the market coverage.
- Proof of Market Recognition: The successful listing represents the authoritative recognition of the product’s quality, compliance and market value by regulatory authorities and procurement platforms, providing strong support for product market promotion.
- Accelerated Commercialization: This listing is a key step from R&D, registration to market implementation of the product, marking that the company’s products have officially entered the market-oriented operation stage, and laying a solid foundation for subsequent sales growth and brand building.
Future Outlook
The successful listing is an important milestone in the commercialization process of women’s health products of Wuhan Heyuan Biotechnology Co., Ltd. In the future, the company will take this opportunity to continuously promote the listing application of products in other provinces across the country, and constantly improve product quality and service capabilities, so as to provide compliant and high-quality health products and solutions for more medical institutions and users, and boost the development of women’s health cause.
Wuhan Heyuan Biotechnology Co., Ltd.
April 20, 2026